See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597264_2018_Blueprint_Medicines_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 7, '00201 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Calc 2)': 4}} |
Graph
Absolute values for 0001597264, Blueprint Medicines Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 685,505,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 24,363,000 |
| 3 | remainder_Assets | 5,869,000 |
| 4 | LiabilitiesCurrent | 42,890,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,986,000 |
| 9 | ResearchAndDevelopmentExpense | 144,687,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 21,426,000 |
| 12 | remainder_NetIncome | 3,128,000 |
| 13 | remainder_ComprehensiveNetIncome | -251,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 715,737,000 |
| 1 | Liabilities | 42,890,000 |
| 2 | Expenses | 172,673,000 |
| 3 | Revenues | 21,426,000 |
| 4 | StockholdersEquity | 672,847,000 |
| 5 | NetIncome | -148,119,000 |
| 6 | ComprehensiveNetIncome | -148,244,500 |
| 7 | BaseVar | 478,052,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.48 |
| 9 | EconomicCapitalRatio | 4.01 |
Edgar->Model Mapping
Feature Distribution
Change over Time
